- Home
- MBRX vs ALCE Comparison
MBRX vs ALCE Comparison
Compare MBRX & ALCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MBRX
- ALCE
- Stock Information
- Founded
- MBRX 2015
- ALCE 2019
- Country
- MBRX United States
- ALCE United States
- Employees
- MBRX N/A
- ALCE N/A
- Industry
- MBRX Biotechnology: Pharmaceutical Preparations
- ALCE Power Generation
- Sector
- MBRX Health Care
- ALCE Utilities
- Exchange
- MBRX Nasdaq
- ALCE Nasdaq
- Market Cap
- MBRX 7.7M
- ALCE 8.6M
- IPO Year
- MBRX 2016
- ALCE N/A
- Fundamental
- Price
- MBRX $2.70
- ALCE $1.75
- Analyst Decision
- MBRX Strong Buy
- ALCE
- Analyst Count
- MBRX 3
- ALCE 0
- Target Price
- MBRX $31.00
- ALCE N/A
- AVG Volume (30 Days)
- MBRX 54.8K
- ALCE 206.9K
- Earning Date
- MBRX 11-08-2024
- ALCE 11-26-2024
- Dividend Yield
- MBRX N/A
- ALCE N/A
- EPS Growth
- MBRX N/A
- ALCE N/A
- EPS
- MBRX N/A
- ALCE N/A
- Revenue
- MBRX N/A
- ALCE N/A
- Revenue This Year
- MBRX N/A
- ALCE N/A
- Revenue Next Year
- MBRX N/A
- ALCE N/A
- P/E Ratio
- MBRX N/A
- ALCE N/A
- Revenue Growth
- MBRX N/A
- ALCE N/A
- 52 Week Low
- MBRX $0.40
- ALCE $1.64
- 52 Week High
- MBRX $6.24
- ALCE $272.25
- Technical
- Relative Strength Index (RSI)
- MBRX 53.82
- ALCE 25.53
- Support Level
- MBRX $2.50
- ALCE $1.71
- Resistance Level
- MBRX $3.33
- ALCE $2.20
- Average True Range (ATR)
- MBRX 0.24
- ALCE 0.28
- MACD
- MBRX 0.04
- ALCE 0.00
- Stochastic Oscillator
- MBRX 39.42
- ALCE 9.43
About MBRX Moleculin Biotech Inc.
Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.
About ALCE Alternus Clean Energy Inc.
Alternus Clean Energy Inc is an international independent clean energy producer. It develops, installs, owns and operates a diverse portfolio of utility-scale solar photovoltaic power stations (PV parks) in Europe and the USA as a long-term owner. The solar parks benefit from long-term government offtake contracts and/or Power Purchase Agreements (PPAs) with investment grade off-takers, plus energy sales to local power grids. It has approximately 8 operating parks, a total of 44 MWp in operation.